TUM – Technical University of Munich Menu
Prof. Percy Knolle (rechts) erforscht mit seiner Arbeitsgruppe unter anderem die Regulation von Immunantworten in der Leber. (Bild: A. Heddergott / TUM)
Prof. Percy Knolle (rechts) erforscht mit seiner Arbeitsgruppe unter anderem die Regulation von Immunantworten in der Leber. (Bild: A. Heddergott / TUM)
  • Research news

Fast, direct route: New signaling pathway discovered for T cell activation in the liver

Synthetic messenger boosts immune system

Specific immune cells, known as T lymphocytes, have to be activated so that the body can develop long-term protection against infections. Previously, it was believed that this process only took place in the lymph nodes and the spleen. But now scientists from Klinikum rechts der Isar at Technische Universität München have discovered that T cells can also be activated in the liver – via a much faster, more direct signaling pathway. The findings, which have been published in Cell Reports, could lead to improvements in the formulation of vaccines.

When a pathogen attacks a healthy cell in the body, T lymphocytes are tasked with identifying and destroying the infected cell. Scientists know that they undergo a “training program” for this task in the lymph nodes or the spleen. “Programming cells” play a key role here, presenting pathogen constituents to the T lymphocytes. This is how the T lymphocytes learn to recognize these components and become specialized “killer” cells. Research teams led by Prof. Percy Knolle from Klinikum rechts der Isar and the University of Bonn and Prof. Stefan Rose-John from the University of Kiel have now discovered a second site where T lymphocytes can be programmed to attack pathogens.

The researchers identified the liver as an immunological organ where special tissue cells act as “programming cells” to prepare the T lymphocytes for their battle against infected cells. They were also able to decrypt the exact molecular code used by these tissue cells to equip the T lymphocytes with special infection-fighting capabilities. “This new mechanism is particularly interesting because the T cells are activated directly and very rapidly – in just 18 hours instead of 72,” explains Percy Knolle.

Synthetic messenger as new adjuvant

The key to all this is a natural messenger from the interleukin family: IL-6/sIL-6R. It only becomes effective when the two individual components (IL-6 and sIL-6R) combine. Previously, scientists were only aware of a role for the substance in regeneration and the development of inflammatory responses. But now the research teams have shown that the T lymphocytes in the liver engage in direct contact with the “programming cells” found there, and that IL-6/sIL-6R very efficiently activates the T cells.

Once the researchers had uncovered this new mechanism, they were able to use a synthetic designer messenger developed by Stefan Rose-John, known as Hyper-IL-6, for the targeted stimulation of T lymphocytes. In this construct, the two individual components which are normally separated are directly and firmly linked to each other. “In combination with the familiar stimulation mechanisms of the T lymphocytes, Hyper-IL-6 can be used to effect a specific ‘hyper stimulation’ of T lymphocytes for particular therapeutic purposes. This could be an important step in helping us improve vaccine formulations,” adds Percy Knolle.

As well as components of the pathogen, current vaccines also contain substances known as adjuvants. After a few intermediate steps, adjuvants indirectly activate the T lymphocytes and help to build up immunity. “We are placing high hopes on hyper-IL-6 as an effective new adjuvant capable of activating T cells directly and thus more rapidly. This could for example help us tackle chronic bacterial or viral infections which have not previously responded to vaccinations,” he concludes.


Original publication

Böttcher J.P., Schanz O., Garbers C., Zaremba A., Hegenbarth S., Kurts C., Beyer M., Schultze J.L., Kastenmüller W., Rose-John S., and Knolle P.A., IL-6 trans-Signaling-Dependent Rapid Development of Cytotoxic CD8+ T Cell Function, Cell Reports, 2014.
DOI: 10.1016/j.celrep.2014.07.008

Contact
Prof. Dr. Percy Knolle
Institute of Molecular Immunology/Experimental Oncology
Klinikum rechts der Isar, Technische Universität München
Tel.: +49 (0)89 4140-6921
percy.knolle(at)tum.de
www.imi.med.tum.de

Corporate Communications Center

Technical University of Munich Dr. Vera Siegler
vera.siegler(at)tum.de

Article at tum.de

Prof. Percy Knolle. (Foto: Heddergott / TUM)

How harmless bacteria can cause fatal infections

About one-third of the fatal cases of liver cirrhosis are attributable to bacterial infections. The damage to the liver cells not only impedes the function of the organ but also weakens the immune response. Scientist at the...

MGCs und Fresszellen (Makrophagen) wurden mit Membran-spezifischen (grau) und Zellkern-spezifischen (blau) Farbstoffen gefärbt. Auf dem Bild sind zwei Riesenzellen zu sehen (Mitte und unten links), die von einigen kleineren, einkernigen Fresszellen umgeben sind. (Bild: Ronny Milde / TUM)

Giant waste bins

If rubbish is too big and unwieldy for normal household waste, its removal becomes the job of specialized experts. Researchers from the Technical University of Munich (TUM) have now discovered, in cooperation with...

Prof. Percy Knolle (Mitte) sucht mit seinem Team am Institut für Molekulare Immunologie unter anderem nach neuen Mechanismen der Immundiagnostik. (Bild: A. Heddergott / TUM)

Cell marker enables prognosis about the course of infections

When a pathogen invades the body, specific cells in the human immune system are ready to take immediate action in order to destroy it. The molecular characteristics of these killer cells were unknown until recently. Now,...

Christoph Vahl, Erstautor der Studie, untersuchte die Tregs und die Rolle ihres T-Zell-Rezeptors. (Foto: C. Vahl / TUM)

T cell receptor ensures Treg functionality

Misdirected immune responses that target the body’s own tissue can result in human diseases. Regulatory T cells known as Tregs combat this effect by suppressing excessive immune responses and responses against our own...

Auf der Abbildung sind Leberzellen zu sehen, deren Zellkerne mit blauem Fluoreszenzfarbstoff angefärbt wurden. In grün ist der metastasenfördernde Botenstoff (SDF1) markiert, dessen Bildung durch TIMP-1 im Lebergewebe ausgelöst wird. (Bild: A. Krüger / TUM)

How metastases develop in the liver

Most tumors are only fatal if the cancer cells spread in the body and form secondary tumors, known as metastases, in other organs, such as the liver. Scientists at Klinikum rechts der Isar of Technische Universität München...

Weil die Arbeit mit Zellen hochreine Bedingungen erfordern, tragen die Mitarbeiter in den Reinräumen sterile Bekleidung. (Foto: M. Neuenhahn / TUM)

Promising T cell therapy

When patients have to undergo a bone marrow transplant, the procedure weakens their immune system. Viruses that are usually kept in check in a healthy immune system may then cause potentially fatal infections. Scientists...